Physician profile
Samuel B Rameas
NPI 1497747471
$3,881.34
in general payments reported to CMS, 2019-2025
10 companies · $1,210 in 2025
The $1,210 reported for 2025 was more than what 83% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $428 · 2020: $503 · 2023: $119 · 2024: $1,621 · 2025: $1,210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,004 · Travel and Lodging: $947.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,003.60 |
| Travel and Lodging | $946.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,408.76 | 2023-2025 | |
| Medical Device Business Services, INC. | $1,074.44 | 2024 | |
| Prodigy Surgical Distribution, INC. | $437.57 | 2020 | |
| Depuy Synthes Sales INC. | $238.31 | 2019-2025 | Motoband |
| Stryker Corporation | $140.10 | 2019-2020 | |
| Integra Lifesciences Corporation | $128.05 | 2019 | |
| Paratek Pharmaceuticals, INC. | $125.00 | 2025 | Nuzyra |
| Organogenesis INC. | $120.33 | 2025 | Puraply Wound Matrix |
| Kci USA, INC. | $106.13 | 2019 | |
| Aroa Biosurgery Incorporated | $102.65 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Rameas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.